|
Volumn 46, Issue 8, 2006, Pages 1261-1263
|
Triptans - Why once?
|
Author keywords
Compliance; Patient education; Patient's decision making; Triptans
|
Indexed keywords
ELETRIPTAN;
NARATRIPTAN;
NONSTEROID ANTIINFLAMMATORY AGENT;
RIZATRIPTAN;
SEROTONIN 1B AGONIST;
SEROTONIN 1D AGONIST;
SUMATRIPTAN;
TRIPTAN DERIVATIVE;
ZOLMITRIPTAN;
ADULT;
AGE;
AGED;
CONTROLLED STUDY;
DECISION MAKING;
DRUG CHOICE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
HEADACHE;
HEALTH MAINTENANCE ORGANIZATION;
HUMAN;
ISRAEL;
MAJOR CLINICAL STUDY;
MALE;
MIGRAINE;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
PRESCRIPTION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
REVIEW;
SEX DIFFERENCE;
SINGLE DRUG DOSE;
ADULT;
AGED;
DRUG PRESCRIPTIONS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MIGRAINE DISORDERS;
PATIENT COMPLIANCE;
PRESCRIPTIONS, DRUG;
RETROSPECTIVE STUDIES;
SEROTONIN AGONISTS;
SEROTONIN RECEPTOR AGONISTS;
|
EID: 33745313039
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2006.00435.x Document Type: Review |
Times cited : (26)
|
References (5)
|